StonvexLoading…
StonvexStonvexStonvexCore line items from VAL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $7.50M | $11.90M | $6.70M | $1.10M |
Operating Income | $20.00M | $477.00M | $437.60M | $307.10M |
Net Income | $-16.40M | $982.80M | $265.30M | $77.20M |
EPS (Diluted) | $-0.24 | $13.86 | $3.73 | $1.08 |
Total Assets | $5.36B | $5.30B | $4.64B | $4.50B |
Total Liabilities | $2.20B | $2.13B | $2.19B | $2.17B |
Cash & Equivalents | $578.30M | $599.40M | $662.70M | $503.40M |
Free Cash Flow OCF − CapEx | $-25.90M | $202.70M | $236.80M | $108.50M |
Shares Outstanding | 69.30M | 69.20M | 69.70M | 71.10M |